Table 3.
Univariate Cox regression analysis
Parameter | OS HR [95% CI] |
p-value | PFS HR [95% CI] |
p-value | LR HR [95% CI] |
p-value |
---|---|---|---|---|---|---|
Treatment Regimen (nCRT + S vs. dCRT) | 0.690 [0.377; 1.264] | 0.230 | 0.643 [0.374; 1.107] | 0.111 | 0.199 [0.068; 0.582] | 0.003 |
Age (continuous) | 1.025 [0.990; 1.061] | 0.160 | 1.025 [0.994; 1.057] | 0.115 | 1.009 [0.966; 1.053] | 0.699 |
Sex (female vs. male) | 0.830 [0.446; 1.545] | 0.557 | 0.807 [0.462; 1.410] | 0.451 | 0.775 [0.334; 1.80] | 0.553 |
Tumor lengths, cm (continuous) | 0.996 [0.899; 1.104] | 0.946 | 1.012 [0.925; 1.107] | 0.798 | 1.022 [0.895; 1.167] | 0.744 |
Tumor location (continuous) | 0.954 [0.907; 1.004] | 0.069 | 0.940 [0.897; 0.985] | 0.010 | 0.844 [0.773; 0.921] | < 0.001 |
T-stage (Tis/T1/2 vs. T3/4) | 1.295 [0.618; 2.714] | 0.493 | 0.966 [0.485; 1.924] | 0.921 | 1.319 [0.524; 3.316] | 0.557 |
N-stage (N0 vs N1) | 1.780 [0.965; 4.560] | 0.230 | 1.167 [0.464; 2.935] | 0.743 | 1.207 [0.284; 5.136] | 0.799 |
Grading (G1/2 vs. G3) | 2.059 [1.084; 3.911] | 0.027 | 1.673 [0.961; 2.912] | 0.069 | 2.065 [0.882; 4.837] | 0.095 |
IQR inter-quartiles-range, OS overall survival, PFS progression-free survival, LR local recurrence, HR Hazard ratio, CI Confidence interval